1.1 An Overview of Recombinant DNA Technology
In 1953, Watson and Crick proposed the double helical structure of DNA.
In the 1960s, Arber, Meselson and others discovered Type I restriction enzymes and ligases enzymes.
In 1972, Paul Berg assembled the first Recombinant DNA from a bacterium into the virus.
In 1975, Köhler and Milstein described the Hybridoma Technique for production of monoclonal antibodies.
In 1982, the first recombinant DNA Therapeutic Product ‘Humulin’ was approved by the FDA.
In 1983, Kary Mullis developed the Polymerase Chain Reaction.
In 1984, Sir Alec Jeffreys invented DNA Fingerprinting.
In 1990, the Human Genome Project was officially initiated.
In 1994, the first genetically engineered crop ‘Flavr Savr’ tomato was introduced.
In 1996, researchers at Monsanto developed Bt cotton and it was first commercially released.
In 2000, Ingo Potrykus and Peter Beyer developed Golden Rice.
In 2003, the Human Genome Project (HGP) was completed.
In 2004, ‘Avastin’, an anti-VEGF monoclonal antibody for cancer treatment was discovered.
In 2006, a recombinant vaccine ‘Gardasil’ against human papillomavirus (HPV) receives FDA approval.
In 2010, Robert Edwards was awarded the Nobel Prize for the development of human in vitro fertilization (IVF) therapy.
In 2012, Shinya Yamanaka and John B. Gurdon discovered that mature differentiated cells can be reprogrammed into Induced Pluripotent Stem Cells.
In 2019, recent advances in the CRISPR-Cas9 genome editing tool were made.
In 2020, vaccines against COVID-19 were developed.
======